Target Profiles
Targeting the Invisible: Decoding the Potential of TRAV4 in Next-Gen Immunotherapy ๐งฌ
The landscape of precision medicine is shifting toward highly specific immune targets. One such emerging frontier is T Cell Receptor Alpha Variable 4 (TRAV4)โa variable segment of the TCR alpha chain that plays a pivotal role in how our immune system recognizes "self" vs. "non-self."
Why TRAV4 Matters:
Disease Associations: Evidence links TRAV4 to specific pMHC recognition in autoimmune conditions like Type 1 Diabetes and Celiac Disease, as well as chronic infectious diseases.
The Druggability Challenge: While its large, flat interaction surface makes small-molecule inhibition difficult, it presents a high-potential "gold mine" for Biologics and Cellular Therapies.
Emerging Strategies: From Bispecific T-Cell Engagers (BiTEs) to engineered TCR-T cell trials, the pipeline is rapidly evolving to redirect potent immune responses with surgical precision.
Despite having no directly approved therapies as of 2024, the clinical pipeline is heating up with Phase I/II trials exploring soluble TCRs and anti-TRAV4 mAbs. ๐
Follow us
Drug Discovery Consulting, Chemistry Solutions and trainings for Biotech, Chemistry Startups and Institutes.
Contact us
Email: info@targetdysinformatics.in
Consulting Services
Target Identification & Proposals: Discovery of novel therapeutic targets with structured, strategic research plans.
Chemistry & Patent Analytics:
Expertise in synthesis, medicinal chemistry, SAR evaluation, hit-to-lead optimization, and intellectual property insights.
ยฉ 2026. All rights reserved.
Training & Courses
PreโIndustrial Trainings: Industryโfocused courses/traionings in pharma, organic synthesis, medicinal, and analytical chemistry tailored for graduates and postgraduates.
Lab Safety Trainings Focused training on chemical handling and safety, emergency protocols, and compliance through interactive workshops.